NSCLC, metastatic
NSCLC, metastatic: Invited Discussant 1301PD, 1302PD and 1303PD
Date
10 Sep 2017Session
NSCLC, metastaticPresenters
Rafal DziadziuszkoAuthors
R. DziadziuszkoAuthor affiliations
- Oncology And Radiotherapy, Medical University of Gdansk, 80-211 - Gdansk/PL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
5032 - A Phase II, randomised, open-label study of Gemcitabine/Carboplatin first-line chemotherapy in combination with or without the antisense oligonucleotide Apatorsen (OGX-427) in advanced squamous cell lung cancers
Presenter: Peter Schmid
Session: NSCLC, metastatic
Resources:
Abstract
Slides
Invited Discussant 1304PD, 1305PD, 1306PD and LBA52
Presenter: Jair Bar
Session: NSCLC, metastatic
Resources:
Slides
Webcast
Invited Discussant 1300PD, LBA53, 1307PD and 1308PD
Presenter: Julien Mazieres
Session: NSCLC, metastatic
Resources:
Slides
Webcast